NEWS
AGREEMENT BETWEEN KEDRION AND PROMETIC FOR THE DEVELOPMENT OF HYPERIMMUNE PRODUCTS
13/03/2008
VISIT OF THE MINISTER OF REFORM AND INNOVATION IN THE PUBLIC ADMINISTRATION, LUIGI NICOLAIS, TO THE KEDRION PLANT IN SANT’ANTIMO (NAPLES)
12/03/2008
PAOLO MARCUCCI HAS JOINED PPTA’S GLOBAL BOARD OF DIRECTORS
28/02/2008
EUROPEAN GMP, CURRENT ISSUES AND FUTURE DEVELOPMENTS: KEDRION IN THE ORGANISING COMMITTEE OF THE EMEA / PDA JOINT CONFERENCE
19/02/2008
PRODUCTION OF PLASMA-DERIVED PRODUCTS TO HIGHEST INTERNATIONAL QUALITY STANDARDS: KEDRION TECHNOLOGY FOR THE NEW MOSCOW PLANT
01/02/2008
KEDRION BUYS A PRODUCTION PLANT IN HUNGARY FROM TEVA PHARMACEUTICAL INDUSTRIES LTD
21/12/2007
KEDRION STAKES ON “VERTICAL INTEGRATION”. TWO AGREEMENTS SIGNED TO BUY FOUR PLASMA COLLECTION CENTRES IN THE USA AND GERMANY
26/11/2007
NEW METHOD FOR PURIFYING PLASMA PROTEINS USED TO TREAT HAEMOPHILIA A AND VON WILLEBRAND DISEASE
31/10/2007
HUMAN PLASMINOGEN ACKNOWLEDGED AS ORPHAN DRUG
15/10/2007
EMAS REGISTRATION FOR KEDRION: THE COMPANY’S ENVIRONMENTAL POLICY REINFORCED.
14/09/2007
RESEARCH PROJECT FOR DEVELOPING A NEW PLASMA DERIVATIVE FOR THE TREATMENT OF HEPATITIS C
20/07/2007
NEW PLANT IN THE KEDRION FACTORY: 7 MILLION INVESTED AND A 50% INCREASE IN PRODUCTION OF FACTOR VIII AND FACTOR IX
15/05/2007
KEDRION AND PROMETIC FORM STRATEGIC ALLIANCE TO DEVELOP ORPHAN DRUGS FROM PLASMA
20/03/2007
KEDRION AND NABI BIOPHARMACEUTICALS ANNOUNCE INITIATION OF CIVACIR® PHASE II 'PROOF-OF-CONCEPT' CLINICAL TRIAL
07/02/2007
PLASMADERIVATIVES: “INVESTITORI ASSOCIATI” INVESTS IN THE SECTOR WITH A 40% SHARE IN LEADING COMPANY KEDRION
18/12/2006
NABI BIOPHARMACEUTICALS SECURES AGREEMENT WITH KEDRION TO CO-DEVELOP AND COMMERCIALIZE CIVACIR® IN EUROPE
07/07/2006
PLASMA SYSTEM, EXPORTING THE ITALIAN “CONTRACT MANUFACTURING” MODEL TO CHILE
12/06/2006
PLASMA DERIVATES: REINFORCING TUSCANY AS LEADER IN THE BALKANS
29/05/2006
VON WILLEBRAND DISEASE”: SIMPLE HANDBOOK
10/05/2006
HAEMOPHILIA: TREATMENT AND CARE “UNDER ANALYSIS”
08/05/2006
FIRST RUSSIAN FACTORY PRODUCING PLASMA-DERIVED PRODUCTS OF INTERNATIONAL STANDARD TO BE SET UP WITH KEDRION TECHNOLOGY
14/02/2006
Working Party on Desmopressin in the management of VWD
16/09/2005
|
